These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 39252179

  • 1. Hyperkalemia burden and treatment patterns in Chinese patients on hemodialysis: final analysis of a prospective multicenter cohort study (PRECEDE-K).
    Jin H, Lu R, Zhang L, Yao L, Shao G, Zuo L, Qin S, Zhang X, Zhang Q, Yu W, Luo Q, Ren Y, Peng H, Xiao J, Yang Q, Chen Q, Shi Y, Ni Z.
    Ren Fail; 2024 Dec; 46(2):2384585. PubMed ID: 39252179
    [Abstract] [Full Text] [Related]

  • 2. Potassium binders for chronic hyperkalaemia in people with chronic kidney disease.
    Natale P, Palmer SC, Ruospo M, Saglimbene VM, Strippoli GF.
    Cochrane Database Syst Rev; 2020 Jun 26; 6(6):CD013165. PubMed ID: 32588430
    [Abstract] [Full Text] [Related]

  • 3. Hyperkalaemia prevalence and dialysis patterns in Chinese patients on haemodialysis: an interim analysis of a prospective cohort study (PRECEDE-K).
    Ni Z, Jin H, Lu R, Zhang L, Yao L, Shao G, Zuo L, Qin S, Zhang X, Zhang Q, Yu W, Luo Q, Ren Y, Peng H, Xiao J, Yang Q, Chen Q, Shi Y, PRECEDE-K study group.
    BMC Nephrol; 2023 Aug 09; 24(1):233. PubMed ID: 37559023
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. DIALIZE China: A Phase IIIb, Randomized, Placebo-Controlled Study to Reduce Predialysis Hyperkalemia With Sodium Zirconium Cyclosilicate in Chinese Patients.
    Ni Z, Lu R, Xu X, Bian X, Zhou Z, Yang J, Luo Q, Chen M, Chen C, Sun X, Yu L, He Q, Jiang H, Yuan W, Li Y, Zhou R, Wang J, Zhang X, Zuo L, Meng X, Chang Z, Zhao J, Wessman P, Xiang P, DIALIZE China Study Group.
    Clin Ther; 2023 Jul 09; 45(7):633-642. PubMed ID: 37385905
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multicentre, observational, retrospective cohort of hyperkalaemia burden at haemodialysis facility-level in China: the Visualize-HD study protocol.
    Zhao X, Zuo L.
    BMJ Open; 2023 Sep 21; 13(9):e066394. PubMed ID: 37734899
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of hyperkalemia and long inter-dialytic interval on morbidity and mortality in patients receiving hemodialysis: a systematic review.
    Bem D, Sugrue D, Wilding B, Zile I, Butler K, Booth D, Tafesse E, McEwan P.
    Ren Fail; 2021 Dec 21; 43(1):241-254. PubMed ID: 33478329
    [Abstract] [Full Text] [Related]

  • 15. Sodium zirconium cyclosilicate reconciles management of hyperkalemia and continuity of renin-angiotensin-aldosterone system inhibitors: a retrospective observational study.
    Kimura W, Minatoguchi S, Mizuno T, Koide S, Hayashi H, Hasegawa M, Inaguma D, Tsuboi N.
    J Nephrol; 2024 Jan 21; 37(1):171-179. PubMed ID: 37608241
    [Abstract] [Full Text] [Related]

  • 16. Current and future potassium binders.
    Bakris GL.
    Nephrol News Issues; 2016 Apr 21; 30(4):suppl 27-31. PubMed ID: 27254903
    [No Abstract] [Full Text] [Related]

  • 17. The burden of hyperkalemia in Germany - a real world evidence study assessing the treatment and costs of hyperkalemia.
    Haas JS, Krinke KS, Maas C, Hardt T, Barck I, Braun S.
    BMC Nephrol; 2020 Aug 08; 21(1):332. PubMed ID: 32770956
    [Abstract] [Full Text] [Related]

  • 18. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
    Lepage L, Dufour AC, Doiron J, Handfield K, Desforges K, Bell R, Vallée M, Savoie M, Perreault S, Laurin LP, Pichette V, Lafrance JP.
    Clin J Am Soc Nephrol; 2015 Dec 07; 10(12):2136-42. PubMed ID: 26576619
    [Abstract] [Full Text] [Related]

  • 19. Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
    Movilli E, Camerini C, Gaggia P, Zubani R, Cancarini G.
    Am J Nephrol; 2018 Dec 07; 48(2):79-86. PubMed ID: 30071530
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
    Georgianos PI, Liampas I, Kyriakou A, Vaios V, Raptis V, Savvidis N, Sioulis A, Liakopoulos V, Balaskas EV, Zebekakis PE.
    Int Urol Nephrol; 2017 Dec 07; 49(12):2217-2221. PubMed ID: 29027620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.